Hepatocellular carcinoma (HCC) is a major health problem worldwide, and it has a poor prognosis. Extrahepatic metastasis from HCC is not unusual, with direct invasion representing the main spreading mode. Sites that are frequently involved are the lung, bone, and lymph nodes. There are few reports of HCC invading the distant gastrointestinal tract, especially hematogenously. Herein we report a case of sigmoid colon metastasis from HCC. The patient was diagnosed with HCC and treated with transcatheter arterial chemoembolization (TACE). Eighteen months after TACE the patient presented with abdominal pain on the left lower quadrant, and a CT scan showed an enhanced mass on the sigmoid colon. Immunohistochemical staining revealed that a tumor cell was positive for polyclonal carcinoembryonic antigen and weakly positive for hepatocyte antigen, supporting the diagnosis of HCC metastasis. The patient underwent anterior resection for the metastatic HCC. (Korean J Hepatol 2010; 16:397-400)
INTRODUCTION

Hepatocellular carcinoma (HCC) is a serious health problem
and has a poor prognosis. HCC accounts for 5.6% of all human cancers with more than 1 million deaths annually and the incidence of HCC is increasing. 1, 2 Despite the implementation of surveillance programs for early HCC, most tumors are diagnosed at intermediate or advanced stages, and only 30% of patients benefit from curative therapies such as resection, liver transplantation, or percutaneous ablation. 2, 3 In the previous autopsy series, extrahepatic metastasis was present in 30~70% of cases and the major organs involved were lung, lymph nodes, bone, and the adrenal gland. 4, 5 Interestingly, involvement of the gastrointestinal (GI) tract from HCC seldom occurs, being found in only 4~6% of cases in the same series 4, 5 and 0.5~2% of cases in another series. 6, 7 Among the GI metastasis from HCC, colon metastasis, especially the left-sided colon, is very rare and mostly occurs through direct invasion. 8, 9 Here, we report on a HCC patient who was treated with transarterial chemoembolization (TACE) and had a solitary metastatic tumor from HCC on his sigmoid colon one and a half years after initial treatment.
CASE REPORT
A 47-year-old man was admitted with a hepatic mass incidentally detected by ultrasound. A computed tomography (CT) scan revealed a 1.7 cm-sized mass in the hepatic segment VI with enhancement on the arterial phase and early washout on the portal phase (Fig. 1A) , and a tiny enhancing nodule on the arterial phase without early washout on the portal phase in segment IV (Fig. 1B) . The patient was a hepatitis B virus (HBV) carrier.
Upon physical examination, superficial lymphadenectasis, icteric sclera, liver palm, or spider telangiectasias were not colonoscopy, a bulging contoured hard mass was noted in the sigmoid colon but the overlying mucosa was intact ( Fig. 2A) .
The CT scan revealed a 4×3.5 cm sized, eccentric mass abutting the sigmoid colon without any lymph node enlargement (Fig. 2B) .
However, the scan did not show any evidence of recurrence in the liver and the portal tract. The patient underwent anterior resection and a well-defined subserosal mass, measuring 5.2×4×3.7 cm, was identified. The cut surface of the mass was grayish white, solid, and granular with hemorrhage and necrosis (Fig. 3A) . The mass extended to the proper muscle layer, however, the overlying mucosa was intact. Histologic examination 3C ). There was no regional lymph node metastasis at the time of surgery and the patient is free of recurrent disease to date for over 4 months.
DISCUSSION
HCC with hematogeous metastasis to colon is very rare. This case shows the typical findings of HCC metastasis to sigmoid colon.
Extrahepatic metastasis of HCC is increasing with prolonged survival and the most frequent sites of metastases are lung, bone, and lymph nodes. On the other hand, GI involvement of HCC is known to be not common. The major mode of metastasis to the GI tract is direct invasion to the contiguous GI tract via adhesion to the serosal side by a bulky tumor mass and the most frequently involved site was the duodenum, followed by the stomach, colon, and jejunum. 6 Rarely, it is hypothesized that HCC may disseminate hematogenously to distant GI tracts. Portal vein thrombosis may be the key point of hematogenous spread to other sites. 7, 10 In our case, it is notable that the HCC was initially a small sized single mass without portal vein thrombosis and metastasized to the left-sided colon one and a half years after TACE. Hematogenous spread was suggested because the metastatic site was distant and the lymph nodes were not involved.
Endoscopic findings of GI metastasis from HCC were varied, such as a raised and centrally ulcerated lesion, mimicking gastric carcinoma, polypoid tumor, or submucosal tumor. 7, 11 Therefore, immunohistochemical findings are important to differentiate HCC from adenocarcinoma in the diagnosis of GI metastasis.
Typically, in HCC, Cam 5.2 staining is positive whereas AE1/AE3 staining is negative. 12 Polyclonal CEA is highly specific for the lining of the biliary canaliculi. 13 Similarly, AFP is another reliable indicator for HCC and it has been reported to be positive A B C in 70~90% of cases.
